SK Innovation (096770)
Korea Exchange · Korea · prices in KRW · close of 27 Oct 2026
Key indicators
| Last close | KRW 138,500.00 |
|---|---|
| 52-week range | 87,700.00 – 165,400.00 |
| Return, 1 month / 3 months | −7.2% / +18.7% |
| Return, 1 year / 3 years | +5.5% / +13.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 45 |
| Volatility (1 year) | 66.8% |
| Worst drawdown (1 year) | -40.3% |
| Average daily value traded | 133,162.91M KRW |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
SK Innovation is a South Korean energy and chemicals company based in Seoul. It refines crude oil and supplies petroleum products and petrochemicals through its energy and chemical businesses, serving industrial customers and fuel markets. The company also makes lithium-ion batteries for electric vehicles through its battery business, supplying automakers. Its operations span refining, chemical materials and battery manufacturing, making it a diversified energy group within the SK corporate family.
On this site SK Innovation appears as a stock on the Korea Exchange (Korea), code 096770, with prices in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
SK Innovation (096770) trades on the Korea Exchange in Korea. It last closed at KRW 138,500.00 on 27 October 2026.
Its price-based Market X-Ray is 79 out of 100 (a strong price profile), ranking 27 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 5.5% and over the last three months it rose 18.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 95 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.0% | ||
| From 52-week high | -15.1% | ||
| Momentum | 87 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 18.7% | ||
| 6-month return | 6.2% | ||
| 12-month return, skipping the last month | 13.6% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 66.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.3% | ||
| Liquidity | 99 · Strong | Trades actively. | |
| Average daily value traded | 133,162.91M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.5% |
|---|---|
| 1 month | −7.2% |
| 3 months | +18.7% |
| 6 months | +6.2% |
| 1 year | +5.5% |
| 3 years | +13.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 140,298.00 / 121,469.00 |
|---|---|
| Golden / death cross (60 days) | Golden, 31 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9,987.80 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 1 Apr 2025 | KRW 2,000.0000 |
| 28 Dec 2022 | KRW 6,038.2914 |
| 29 Dec 2021 | KRW 0.0108 |
| 29 Dec 2020 | KRW 1,447.5356 |
| 29 Jun 2020 | KRW 1,654.3264 |
| 27 Dec 2019 | KRW 1,370.9898 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.